Ro09-9212 is a thienodiazepine derivative with sedative and anxiolytic effects, which has been sold as a designer drug.[1][2]

Ro09-9212
Identifiers
  • 7-chloro-5-(2-chlorophenyl)-1,3-dihydrothieno[2,3-e][1,4]diazepin-2-one
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H8Cl2N2OS
Molar mass311.18 g·mol−1
3D model (JSmol)
  • C1C(=O)NC2=C(C=C(S2)Cl)C(=N1)C3=CC=CC=C3Cl
  • InChI=1S/C13H8Cl2N2OS/c14-9-4-2-1-3-7(9)12-8-5-10(15)19-13(8)17-11(18)6-16-12/h1-5H,6H2,(H,17,18)
  • Key:QBZXYZQVZOKZRX-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ US 4155913, Hellerbach J, Zeller P, Binder D, Hromatka O, "Thienotriazolodiazepine derivatives.", issued 22 May 1979, assigned to Hoffmann La Roche Inc 
  2. ^ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals. 14 (8). Basel, Switzerland: 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.